Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | DrugBank | Drug (Description in trials) | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 |
Acazicolcept
(Fc fusion protein of a human inducible T cell costimulator ligand variant immunoglobulin domain designed to inhibit simultaneously the CD28 and ICOS inflammation pathways) | [1] Acazicolcept Acazicolcept | [1] Acazicolcept
Acazicolcept
💬
| [2] CD28 CD28,ICOS 💬 | [13] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, Rheumatoid arthritis, Systemic lupus erythematosus, T cell receptor signaling pathway, Type I diabetes mellitus, Viral myocarditis 💬 | [1] 49 49 💬
|
| 2 |
AMT-101
(Recombinant human interleukin-10 fusion protein) | [1] AMT-101 AMT-101 | - | - | - | [2] 46 46, 97 💬
|
| 3 |
Batiraxcept
(Axl fc fusion protein avb-s6-500) | [1] AVB-S6-500 AVB-S6-500 | [1] Batiraxcept
Batiraxcept
💬
| [1] AXL AXL 💬
| [1] Efferocytosis Efferocytosis 💬 | [1] 66 66 💬
|
| 4 |
Efavaleukin alfa
(Fc il-2 mutein fusion protein) | [1] Efavaleukin alfa Efavaleukin alfa | [1] Efavaleukin alfa
Efavaleukin alfa
💬
| - | - | [2] 49 49, 97 💬
|
| 5 |
Efzofitimod
(Human IgG1Fc- iMod domain of human HARS fusion protein) | [1] Efzofitimod Efzofitimod | [1] Efzofitimod
Efzofitimod
💬
| [2] HARS HARS,HARS 💬 | [1] Aminoacyl-tRNA biosynthesis Aminoacyl-tRNA biosynthesis 💬 | [2] 51 51, 84 💬
|
| 6 |
Froniglutide
(Glucagon like peptide-1 Elastin like peptide-120 fusion protein) | [1] Froniglutide Froniglutide | - | - | - | [1] 50 50 💬
|
| 7 |
Goflikicept
(Heterodimeric fusion protein that binds to IL-1 beta consisting of human extracellular domain of IL1 receptor and a mutant Fc fragment of human IGg1 and part of human IL1 receptor accessory protein) | [1] RPH-104 RPH-104 | - | - | - | [2] 54 54, 266 💬
|
| 8 |
MK-2225
(Homodimeric fragment crystallizable fusion protein comprised of the extracellular domain of the human transforming growth factor beta receptor type II linked to a human IgG1 Fc domain) | [1] MK-2225 MK-2225 | - | - | - | [1] 51 51 💬
|
| 9 |
Telitacicept
(FUSION PROTEIN WITH HUMAN IMMUNOGLOBULIN G1) | [1] Telitacicept Telitacicept | - | - | - | [11] 11 11, 13, 46, 48, 49, 51, 53, 63, 66, 222, 300 💬
|
| 10 |
Tralesinidase alfa
(NAGLU-IGF2 fusion protein) | [2] Rhnaglu-IGF2 Rhnaglu-IGF2; Tralesinidase alfa | - | - | - | [1] 19 19 💬
|
| 11 |
Vasomera
(Vasoactive intestinal peptide fusion protein) | [0] | - | - | - | [1] 86 86 💬
|
